Structure

Physi-Chem Properties

Molecular Weight:  572.15
Volume:  543.89
LogP:  1.895
LogD:  1.324
LogS:  -3.702
# Rotatable Bonds:  9
TPSA:  215.83
# H-Bond Aceptor:  13
# H-Bond Donor:  8
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.109
Synthetic Accessibility Score:  4.122
Fsp3:  0.25
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.324
MDCK Permeability:  8.575754691264592e-06
Pgp-inhibitor:  0.006
Pgp-substrate:  0.142
Human Intestinal Absorption (HIA):  0.681
20% Bioavailability (F20%):  0.672
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.019
Plasma Protein Binding (PPB):  93.63530731201172%
Volume Distribution (VD):  0.411
Pgp-substrate:  2.970266819000244%

ADMET: Metabolism

CYP1A2-inhibitor:  0.608
CYP1A2-substrate:  0.049
CYP2C19-inhibitor:  0.035
CYP2C19-substrate:  0.042
CYP2C9-inhibitor:  0.289
CYP2C9-substrate:  0.299
CYP2D6-inhibitor:  0.074
CYP2D6-substrate:  0.188
CYP3A4-inhibitor:  0.283
CYP3A4-substrate:  0.023

ADMET: Excretion

Clearance (CL):  8.538
Half-life (T1/2):  0.931

ADMET: Toxicity

hERG Blockers:  0.335
Human Hepatotoxicity (H-HT):  0.054
Drug-inuced Liver Injury (DILI):  0.87
AMES Toxicity:  0.471
Rat Oral Acute Toxicity:  0.012
Maximum Recommended Daily Dose:  0.023
Skin Sensitization:  0.961
Carcinogencity:  0.218
Eye Corrosion:  0.003
Eye Irritation:  0.889
Respiratory Toxicity:  0.026

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC33298

Natural Product ID:  NPC33298
Common Name*:   [(2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[3-Hydroxy-5-[(E)-2-(3-Hydroxy-4-Methoxyphenyl)Ethenyl]Phenoxy]Oxan-2-Yl]Methyl 3,4,5-Trihydroxybenzoate
IUPAC Name:   [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
Synonyms:  
Standard InCHIKey:  HEOKFDGOFROELJ-XJVIDBJFSA-N
Standard InCHI:  InChI=1S/C28H28O13/c1-38-21-5-4-13(8-18(21)30)2-3-14-6-16(29)11-17(7-14)40-28-26(36)25(35)24(34)22(41-28)12-39-27(37)15-9-19(31)23(33)20(32)10-15/h2-11,22,24-26,28-36H,12H2,1H3/b3-2+/t22-,24-,25+,26-,28-/m1/s1
SMILES:  COc1ccc(/C=C/c2cc(cc(c2)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](COC(=O)c3cc(c(c(c3)O)O)O)O2)O)O)O)O)cc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL113598
PubChem CID:   10076782
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000253] Stilbenes
        • [CHEMONTID:0000142] Stilbene glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO88 Rheum undulatum Species Polygonaceae Eukaryota rhizome n.a. n.a. PMID[10714491]
NPO88 Rheum undulatum Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO88 Rheum undulatum Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus IC50 = 11000.0 nM PMID[540338]
NPT544 Protein Family Estrogen receptor Homo sapiens FC = 1.1 n.a. PMID[540339]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC33298 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC285108
0.9869 High Similarity NPC289346
0.9804 High Similarity NPC160780
0.9804 High Similarity NPC289811
0.9742 High Similarity NPC90905
0.9742 High Similarity NPC4013
0.974 High Similarity NPC239966
0.974 High Similarity NPC203020
0.9739 High Similarity NPC133984
0.9739 High Similarity NPC1913
0.9684 High Similarity NPC658
0.9684 High Similarity NPC197708
0.9677 High Similarity NPC311803
0.9677 High Similarity NPC472859
0.9677 High Similarity NPC25389
0.9613 High Similarity NPC166277
0.9613 High Similarity NPC119125
0.961 High Similarity NPC472860
0.9563 High Similarity NPC5786
0.9563 High Similarity NPC102851
0.9548 High Similarity NPC287872
0.9548 High Similarity NPC74319
0.9542 High Similarity NPC194095
0.9542 High Similarity NPC191046
0.9542 High Similarity NPC327032
0.9503 High Similarity NPC88560
0.9503 High Similarity NPC172033
0.9503 High Similarity NPC175230
0.95 High Similarity NPC149011
0.95 High Similarity NPC204937
0.9477 High Similarity NPC310661
0.9477 High Similarity NPC105827
0.9437 High Similarity NPC95421
0.9437 High Similarity NPC198125
0.9419 High Similarity NPC471405
0.9412 High Similarity NPC134905
0.9412 High Similarity NPC36130
0.9387 High Similarity NPC67629
0.9387 High Similarity NPC79736
0.9383 High Similarity NPC472993
0.9375 High Similarity NPC116745
0.9367 High Similarity NPC148273
0.9363 High Similarity NPC53889
0.9355 High Similarity NPC10205
0.9351 High Similarity NPC3746
0.9351 High Similarity NPC205037
0.9351 High Similarity NPC44260
0.9351 High Similarity NPC16024
0.9351 High Similarity NPC61152
0.9329 High Similarity NPC267549
0.9317 High Similarity NPC149300
0.9308 High Similarity NPC121290
0.9299 High Similarity NPC87317
0.9286 High Similarity NPC75695
0.9268 High Similarity NPC472991
0.9268 High Similarity NPC472992
0.9264 High Similarity NPC163165
0.9255 High Similarity NPC473818
0.9245 High Similarity NPC41009
0.9241 High Similarity NPC476373
0.9241 High Similarity NPC24164
0.9236 High Similarity NPC156818
0.9236 High Similarity NPC68324
0.9236 High Similarity NPC289322
0.9236 High Similarity NPC38779
0.9236 High Similarity NPC160512
0.9236 High Similarity NPC114179
0.9226 High Similarity NPC137813
0.9226 High Similarity NPC157898
0.9221 High Similarity NPC140151
0.9216 High Similarity NPC111785
0.9216 High Similarity NPC92117
0.9212 High Similarity NPC217520
0.9212 High Similarity NPC476620
0.9212 High Similarity NPC139571
0.9212 High Similarity NPC476618
0.9212 High Similarity NPC476623
0.9212 High Similarity NPC476619
0.9212 High Similarity NPC476621
0.9212 High Similarity NPC476622
0.9212 High Similarity NPC35167
0.9212 High Similarity NPC472387
0.9207 High Similarity NPC84482
0.9207 High Similarity NPC169645
0.9202 High Similarity NPC47140
0.9202 High Similarity NPC67134
0.9202 High Similarity NPC172807
0.9202 High Similarity NPC211594
0.9202 High Similarity NPC254540
0.9198 High Similarity NPC229687
0.9187 High Similarity NPC88043
0.9172 High Similarity NPC250436
0.9172 High Similarity NPC300845
0.9172 High Similarity NPC88803
0.9172 High Similarity NPC104983
0.9172 High Similarity NPC291948
0.9162 High Similarity NPC36138
0.9157 High Similarity NPC471030
0.9156 High Similarity NPC473091
0.9152 High Similarity NPC61904
0.9152 High Similarity NPC144097
0.9152 High Similarity NPC297574
0.915 High Similarity NPC120621
0.915 High Similarity NPC248257
0.9146 High Similarity NPC4390
0.9136 High Similarity NPC229729
0.9136 High Similarity NPC45400
0.913 High Similarity NPC22832
0.913 High Similarity NPC165720
0.913 High Similarity NPC311830
0.913 High Similarity NPC142614
0.9125 High Similarity NPC476371
0.9125 High Similarity NPC476372
0.9114 High Similarity NPC238419
0.9114 High Similarity NPC226759
0.9114 High Similarity NPC172419
0.9108 High Similarity NPC145425
0.9107 High Similarity NPC470416
0.9096 High Similarity NPC267680
0.9096 High Similarity NPC113836
0.9096 High Similarity NPC37668
0.9096 High Similarity NPC253521
0.9096 High Similarity NPC477895
0.9096 High Similarity NPC293626
0.9096 High Similarity NPC217387
0.9096 High Similarity NPC258044
0.9096 High Similarity NPC196127
0.9091 High Similarity NPC98809
0.9091 High Similarity NPC34267
0.9091 High Similarity NPC477848
0.9091 High Similarity NPC476394
0.9091 High Similarity NPC223426
0.9091 High Similarity NPC214621
0.9091 High Similarity NPC81042
0.9085 High Similarity NPC307518
0.9085 High Similarity NPC175107
0.9085 High Similarity NPC472386
0.9085 High Similarity NPC153755
0.9085 High Similarity NPC48773
0.9085 High Similarity NPC205076
0.9085 High Similarity NPC190003
0.908 High Similarity NPC201292
0.908 High Similarity NPC226294
0.908 High Similarity NPC186807
0.908 High Similarity NPC93337
0.908 High Similarity NPC45638
0.908 High Similarity NPC105025
0.908 High Similarity NPC469931
0.908 High Similarity NPC58053
0.908 High Similarity NPC475942
0.9074 High Similarity NPC236934
0.9074 High Similarity NPC5778
0.9068 High Similarity NPC88023
0.9068 High Similarity NPC243930
0.9068 High Similarity NPC191306
0.9068 High Similarity NPC19709
0.9068 High Similarity NPC270335
0.9068 High Similarity NPC168822
0.9068 High Similarity NPC222936
0.9068 High Similarity NPC284960
0.9068 High Similarity NPC309025
0.9062 High Similarity NPC217950
0.9051 High Similarity NPC318432
0.9051 High Similarity NPC247629
0.9051 High Similarity NPC239019
0.9048 High Similarity NPC35924
0.9048 High Similarity NPC199172
0.9042 High Similarity NPC80956
0.9036 High Similarity NPC472723
0.9036 High Similarity NPC211532
0.9036 High Similarity NPC233994
0.9036 High Similarity NPC472385
0.9036 High Similarity NPC296018
0.9036 High Similarity NPC198324
0.9036 High Similarity NPC154741
0.9032 High Similarity NPC205054
0.903 High Similarity NPC34436
0.903 High Similarity NPC166674
0.903 High Similarity NPC219600
0.903 High Similarity NPC46640
0.903 High Similarity NPC263119
0.903 High Similarity NPC316539
0.9026 High Similarity NPC142528
0.9026 High Similarity NPC472969
0.9024 High Similarity NPC471416
0.9024 High Similarity NPC51326
0.9024 High Similarity NPC183357
0.9024 High Similarity NPC155763
0.9024 High Similarity NPC224462
0.9024 High Similarity NPC34287
0.9024 High Similarity NPC105511
0.9024 High Similarity NPC235260
0.9024 High Similarity NPC21190
0.9024 High Similarity NPC244776
0.9024 High Similarity NPC44558
0.9024 High Similarity NPC474434
0.9024 High Similarity NPC22195
0.9024 High Similarity NPC206123
0.9024 High Similarity NPC20505
0.9024 High Similarity NPC116864

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC33298 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9172 High Similarity NPD4868 Clinical (unspecified phase)
0.8976 High Similarity NPD4338 Clinical (unspecified phase)
0.8963 High Similarity NPD7054 Approved
0.8909 High Similarity NPD7472 Approved
0.8909 High Similarity NPD7074 Phase 3
0.8902 High Similarity NPD3818 Discontinued
0.8743 High Similarity NPD6797 Phase 2
0.869 High Similarity NPD7251 Discontinued
0.8667 High Similarity NPD6166 Phase 2
0.8667 High Similarity NPD6168 Clinical (unspecified phase)
0.8667 High Similarity NPD6167 Clinical (unspecified phase)
0.8642 High Similarity NPD4381 Clinical (unspecified phase)
0.8639 High Similarity NPD7808 Phase 3
0.8631 High Similarity NPD7993 Clinical (unspecified phase)
0.858 High Similarity NPD7685 Pre-registration
0.8544 High Similarity NPD6980 Clinical (unspecified phase)
0.8512 High Similarity NPD5844 Phase 1
0.8509 High Similarity NPD1934 Approved
0.8491 Intermediate Similarity NPD1653 Approved
0.8344 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD1465 Phase 2
0.8344 Intermediate Similarity NPD2801 Approved
0.8343 Intermediate Similarity NPD7228 Approved
0.8293 Intermediate Similarity NPD3817 Phase 2
0.8263 Intermediate Similarity NPD7199 Phase 2
0.8256 Intermediate Similarity NPD6559 Discontinued
0.8253 Intermediate Similarity NPD6234 Discontinued
0.8242 Intermediate Similarity NPD3882 Suspended
0.8239 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD230 Phase 1
0.8228 Intermediate Similarity NPD6190 Approved
0.8205 Intermediate Similarity NPD7266 Discontinued
0.8187 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8171 Intermediate Similarity NPD37 Approved
0.8133 Intermediate Similarity NPD4967 Phase 2
0.8133 Intermediate Similarity NPD4966 Approved
0.8133 Intermediate Similarity NPD4965 Approved
0.8107 Intermediate Similarity NPD6232 Discontinued
0.8084 Intermediate Similarity NPD7075 Discontinued
0.8068 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD4380 Phase 2
0.8012 Intermediate Similarity NPD1511 Approved
0.8 Intermediate Similarity NPD7411 Suspended
0.7965 Intermediate Similarity NPD7473 Discontinued
0.7964 Intermediate Similarity NPD5402 Approved
0.7937 Intermediate Similarity NPD4628 Phase 3
0.7914 Intermediate Similarity NPD1512 Approved
0.7904 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD5494 Approved
0.7853 Intermediate Similarity NPD8312 Approved
0.7853 Intermediate Similarity NPD8313 Approved
0.7845 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD6801 Discontinued
0.7841 Intermediate Similarity NPD7240 Approved
0.7833 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD7819 Suspended
0.7798 Intermediate Similarity NPD8455 Phase 2
0.7791 Intermediate Similarity NPD6799 Approved
0.7758 Intermediate Similarity NPD5403 Approved
0.7751 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD3027 Phase 3
0.7714 Intermediate Similarity NPD3751 Discontinued
0.7707 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD1613 Approved
0.7702 Intermediate Similarity NPD1549 Phase 2
0.7701 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD1933 Approved
0.7654 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD5353 Approved
0.764 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD5401 Approved
0.7636 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD6959 Discontinued
0.7613 Intermediate Similarity NPD9494 Approved
0.7607 Intermediate Similarity NPD3750 Approved
0.7604 Intermediate Similarity NPD8151 Discontinued
0.7602 Intermediate Similarity NPD7768 Phase 2
0.7586 Intermediate Similarity NPD3787 Discontinued
0.758 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD3749 Approved
0.7547 Intermediate Similarity NPD447 Suspended
0.753 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7526 Intermediate Similarity NPD7680 Approved
0.7516 Intermediate Similarity NPD9269 Phase 2
0.7515 Intermediate Similarity NPD6599 Discontinued
0.75 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD2796 Approved
0.7469 Intermediate Similarity NPD1551 Phase 2
0.7452 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD7038 Approved
0.7444 Intermediate Similarity NPD7039 Approved
0.7443 Intermediate Similarity NPD5242 Approved
0.7436 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD7783 Phase 2
0.7435 Intermediate Similarity NPD7435 Discontinued
0.7421 Intermediate Similarity NPD6233 Phase 2
0.7407 Intermediate Similarity NPD1510 Phase 2
0.7389 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD7585 Approved
0.7368 Intermediate Similarity NPD6780 Approved
0.7368 Intermediate Similarity NPD6776 Approved
0.7368 Intermediate Similarity NPD6778 Approved
0.7368 Intermediate Similarity NPD6781 Approved
0.7368 Intermediate Similarity NPD6385 Approved
0.7368 Intermediate Similarity NPD6782 Approved
0.7368 Intermediate Similarity NPD6777 Approved
0.7368 Intermediate Similarity NPD6779 Approved
0.7368 Intermediate Similarity NPD6386 Approved
0.7355 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD7458 Discontinued
0.7353 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD3926 Phase 2
0.733 Intermediate Similarity NPD8127 Discontinued
0.7322 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7583 Approved
0.7314 Intermediate Similarity NPD919 Approved
0.7301 Intermediate Similarity NPD3748 Approved
0.7267 Intermediate Similarity NPD1240 Approved
0.7267 Intermediate Similarity NPD943 Approved
0.7256 Intermediate Similarity NPD2935 Discontinued
0.7255 Intermediate Similarity NPD9268 Approved
0.725 Intermediate Similarity NPD6798 Discontinued
0.7233 Intermediate Similarity NPD4908 Phase 1
0.7231 Intermediate Similarity NPD7584 Approved
0.7229 Intermediate Similarity NPD6674 Discontinued
0.7226 Intermediate Similarity NPD1091 Approved
0.7219 Intermediate Similarity NPD2533 Approved
0.7219 Intermediate Similarity NPD2532 Approved
0.7219 Intermediate Similarity NPD2534 Approved
0.7216 Intermediate Similarity NPD7870 Phase 2
0.7216 Intermediate Similarity NPD7871 Phase 2
0.7211 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD7874 Approved
0.719 Intermediate Similarity NPD9545 Approved
0.7186 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD1607 Approved
0.7176 Intermediate Similarity NPD6273 Approved
0.7165 Intermediate Similarity NPD7698 Approved
0.7165 Intermediate Similarity NPD7696 Phase 3
0.7165 Intermediate Similarity NPD7697 Approved
0.7159 Intermediate Similarity NPD6971 Discontinued
0.7151 Intermediate Similarity NPD3226 Approved
0.7151 Intermediate Similarity NPD8434 Phase 2
0.7143 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3764 Approved
0.7135 Intermediate Similarity NPD1247 Approved
0.7134 Intermediate Similarity NPD7097 Phase 1
0.7126 Intermediate Similarity NPD1652 Phase 2
0.712 Intermediate Similarity NPD7549 Discontinued
0.7113 Intermediate Similarity NPD6823 Phase 2
0.7107 Intermediate Similarity NPD7701 Phase 2
0.7105 Intermediate Similarity NPD6534 Approved
0.7105 Intermediate Similarity NPD6535 Approved
0.7104 Intermediate Similarity NPD5953 Discontinued
0.7095 Intermediate Similarity NPD7229 Phase 3
0.707 Intermediate Similarity NPD1608 Approved
0.7069 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD4357 Discontinued
0.7059 Intermediate Similarity NPD8150 Discontinued
0.7052 Intermediate Similarity NPD3455 Phase 2
0.7044 Intermediate Similarity NPD1203 Approved
0.7041 Intermediate Similarity NPD8319 Approved
0.7041 Intermediate Similarity NPD8320 Phase 1
0.7035 Intermediate Similarity NPD920 Approved
0.7019 Intermediate Similarity NPD6832 Phase 2
0.7012 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD5124 Phase 1
0.701 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7440 Discontinued
0.7 Intermediate Similarity NPD7801 Approved
0.6995 Remote Similarity NPD7699 Phase 2
0.6995 Remote Similarity NPD7700 Phase 2
0.6995 Remote Similarity NPD7286 Phase 2
0.6988 Remote Similarity NPD7033 Discontinued
0.6982 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6982 Remote Similarity NPD4110 Phase 3
0.6982 Remote Similarity NPD8166 Discontinued
0.6981 Remote Similarity NPD3225 Approved
0.6946 Remote Similarity NPD6099 Approved
0.6946 Remote Similarity NPD6100 Approved
0.6942 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6919 Remote Similarity NPD642 Clinical (unspecified phase)
0.6918 Remote Similarity NPD2983 Phase 2
0.6918 Remote Similarity NPD2982 Phase 2
0.6909 Remote Similarity NPD6355 Discontinued
0.6905 Remote Similarity NPD2346 Discontinued
0.6903 Remote Similarity NPD5536 Phase 2
0.6899 Remote Similarity NPD422 Phase 1
0.689 Remote Similarity NPD4062 Phase 3
0.6886 Remote Similarity NPD2799 Discontinued
0.6886 Remote Similarity NPD4308 Phase 3
0.6886 Remote Similarity NPD651 Clinical (unspecified phase)
0.6879 Remote Similarity NPD17 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data